Stent Platform
• Fully degradable poly(L-lactide)
• Sine wave structure in space, In-phase peak-valley connection
Drug coating
• Fully degradable poly(D,L-lactide)
• Effectively control sirolimus release rate
Drug
• Classical Sirolimus with dose of 15.3ug/mm
• Inhibit the proliferation and migration of smooth muscle cells
Delivery system
• Completely self-developed second-generation rapid-exchange balloon dilatation catheter
• Superior pushability and crossability
![](/uploads/s/q/i/m/qimvmp501gj4/img/full_YH8WFO6W.png)
NeoVas
Sirolimus-eluting Bioresorbable Coronary Stent System
Ordering Information
![](/uploads/s/q/i/m/qimvmp501gj4/img/full_cuPBHoSS.jpg)
Compliance Chart
![](/uploads/s/q/i/m/qimvmp501gj4/img/full_HxVvSMpE.jpg)